Database Query Results : Electrical Pulses, ,

EP, Electrical Pulses: Click to Expand ⟱
Features:

Electrical Pulses (Pulsed Electric Field therapies; PEF) are a bioelectromagnetic modality in oncology that delivers brief, high-voltage (or high-field) pulses to tissue to permeabilize membranes and/or ablate tumors. Clinically relevant categories commonly discussed:
(1) Reversible electroporation for drug/ion delivery (Electrochemotherapy, ECT; Calcium electroporation),
(2) Irreversible electroporation ablation (IRE; e.g., NanoKnife-type approaches), and
(3) Nanosecond PEF (nsPEF) aimed at intracellular targets.
Primary mechanisms (ranked):
1) Membrane electroporation → rapid loss of ionic homeostasis / enhanced transport (ECT) or irreversible disruption (IRE).
2) Ca2+ dysregulation (influx + organelle Ca2+ stress) → mitochondrial depolarization, ER stress, apoptosis/necrosis spectrum (pulse-width dependent).
3) Stress biology (ROS↑, inflammatory/DAMP signaling) → immunogenic cell death signals and microenvironment remodeling (often secondary/adaptive).
PK/Bioavailability relevance: systemic PK is mainly relevant only for ECT (bleomycin/cisplatin timing, tissue exposure); field-based effects themselves are local and device/geometry-limited rather than concentration-limited.
In-vitro vs systemic exposure: not concentration-driven (electric field–driven); however, many in-vitro protocols use idealized field homogeneity not achievable in heterogeneous tumors without image-guided electrode placement.
Clinical evidence: ECT and IRE have substantial human use (ECT for cutaneous/superficial tumors; IRE for selected solid tumors near critical structures). nsPEF remains mostly preclinical/early human and is still device- and protocol-evolving.

Electrical Pulses / PEF Oncology Modality — Ranked Mechanistic Axes

Rank Pathway / Axis Cancer Cells (↑ / ↓ / ↔) Normal Cells (↑ / ↓ / ↔) TSF Primary Effect Notes / Interpretation
1 Membrane electroporation (Reversible vs Irreversible) ↑ permeabilization / disruption ↑ permeabilization / disruption P Immediate loss of membrane barrier Category mapping: Reversible EP → ECT / Ca-EP; Irreversible EP → IRE. Selectivity is largely geometric (field distribution) and cellular (repair capacity), not “cancer-only”.
2 ECT drug uptake (bleomycin/cisplatin) / intracellular access ↑ intracellular drug delivery ↑ intracellular drug delivery P→R Local chemosensitization Category: ECT is a delivery amplifier; efficacy depends on timing + local perfusion. Often enables potent effect from otherwise poorly permeant agents.
3 Ca2+ axis (influx, overload, ER–mitochondria coupling) ↑ Ca2+ dysregulation ↑ Ca2+ dysregulation P→R Mitochondrial stress, apoptosis/necrosis spectrum Pulse width and repetition strongly shape outcome; Ca electroporation leverages Ca2+-driven bioenergetic collapse as a drug-free approach.
4 Mitochondria / MPTP + bioenergetic collapse ↑ depolarization / ATP loss ↑ depolarization / ATP loss R Cell death execution + metabolic failure Often downstream of Ca2+ overload + membrane failure; nsPEF is frequently framed as more “intracellular/organellar” stress-forward than classic µs EP.
5 ROS (oxidative burst → signaling) ↑ (context-dependent) ↑ (context-dependent) R→G Stress signaling, damage amplification ROS can be secondary to Ca2+/mitochondria and/or electrochemical effects at electrodes. Direction and magnitude depend on pulse protocol, conductivity, and oxygenation.
6 NRF2 antioxidant response / adaptation ↑ (context-dependent; resistance role) ↑ (protective role) G Redox adaptation NRF2 upshifts can protect normal tissue but may also support tumor survival post-sublethal EP (repair/tolerance). Relevance rises when aiming for non-ablative or fractionated protocols.
7 Vascular axis (perfusion, endothelial effects) ↓ perfusion (often) / local ischemia ↓ perfusion (local) R Secondary tumor control via antivascular effects Prominent in ECT literature (composite antivascular + cytotoxic). In IRE, ECM sparing may preserve larger structures while still affecting microvasculature.
8 Immunogenic cell death / DAMP release ↑ immune priming signals ↔ (tissue-dependent) G Local-to-systemic immune modulation (adjunct potential) Most compelling as an adjunct (combo with checkpoint blockade, RT, etc.). Strength varies with ablation completeness, antigen burden, and microenvironment.
9 Clinical Translation Constraint Deliverability / safety / field heterogeneity Constraints are dominated by geometry (electrode placement, tumor shape, conductivity), safety (muscle contractions, arrhythmia risk near heart, anesthesia needs), and protocol standardization; nsPEF still has broader device/protocol variability than ECT/IRE.


Scientific Papers found: Click to Expand⟱
933- CUR,  EP,    Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: A global proteomics study
- in-vitro, BC, NA
Apoptosis↑, ALDOA↓, ENO2↓, LDHA↓, LDHB↓, PFKP↓, PGK1↓, PGM1↓, PGAM1↓, OXPHOS↑, TCA↑,
3460- EP,    Picosecond pulsed electric fields induce apoptosis in HeLa cells via the endoplasmic reticulum stress and caspase-dependent signaling pathways
- in-vitro, Cerv, HeLa
tumCV↓, Apoptosis↑, TumCCA↑, GRP78/BiP↑, GRP94↑, CEBPA↑, CHOP↑, Ca+2↑, Casp12↑, Casp9↑, Casp3↑, Cyt‑c↑, BAX↑, Bcl-2↓, ER Stress↑, MMP↓,
5256- EP,    Pulsed electric fields: a sharp sword in the battle against cancers
- Review, Var, NA
BioAv↑, TumCD↑, MMP↓, Apoptosis↑, TumCCA↑, Imm↑, RadioS↑, ChemoSen↑,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

OXPHOS↑, 1,  

Mitochondria & Bioenergetics

MMP↓, 2,  

Core Metabolism/Glycolysis

ALDOA↓, 1,   ENO2↓, 1,   LDHA↓, 1,   LDHB↓, 1,   PFKP↓, 1,   PGAM1↓, 1,   PGK1↓, 1,   PGM1↓, 1,   TCA↑, 1,  

Cell Death

Apoptosis↑, 3,   BAX↑, 1,   Bcl-2↓, 1,   Casp12↑, 1,   Casp3↑, 1,   Casp9↑, 1,   Cyt‑c↑, 1,   TumCD↑, 1,  

Transcription & Epigenetics

tumCV↓, 1,  

Protein Folding & ER Stress

CHOP↑, 1,   ER Stress↑, 1,   GRP78/BiP↑, 1,   GRP94↑, 1,  

Cell Cycle & Senescence

TumCCA↑, 2,  

Proliferation, Differentiation & Cell State

CEBPA↑, 1,  

Migration

Ca+2↑, 1,  

Immune & Inflammatory Signaling

Imm↑, 1,  

Drug Metabolism & Resistance

BioAv↑, 1,   ChemoSen↑, 1,   RadioS↑, 1,  
Total Targets: 31

Pathway results for Effect on Normal Cells:


Total Targets: 0

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:248  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page